Drug â€excipient Interaction of Anti-tubercular Drugs

Drug excipient Interaction of Anti-tubercular DrugsDrug excipient fundamental fundamental interaction of anti-tubercular medicates and its in-silico evaluationAbstractisoniazid and Pyrazinamide are the outgrowth line anti tubercular drugs. milk sugar is in the first place employ as the excipient in solid loony toons reachs of isoniazid and pyrazinamide. These drugs contains autochthonic and secondary aminic functional conference which interacts with milk sugar by maillard answer and form draw. The maillard reply pulls of isoniazid and pyrazinamide with milk sugar were synthesized at 60oC in alcalescent borate buffer pH 9.2 and characterized by UV, FT-IR, DSC, HPLC and MS. go into workplace for in-sillico evaluation of isoniazid- milk sugar draw and pyrazinamide-lactose draw was performed to paper its effect on pharmacological activeness. The present study shows the presence of incompatibility between isoniazid and pyazinamidewith lactose which leads to loss the remedial effect of isoniazid and pyrazinamide.Keywords isoniazid, pyrazinamide, lactose, maillard answer, excipient, incompatibility, dosage form.IntroductionExcipients are traditionally disclose known as promoters of degradation than as stabilizers of drug substances (Crowley 1999). Physicochemical and physiological process e.g. stability, physiological pH, gastrointestinal transit time, disintegration, dissolution, permeability and bioavailability lot be altered by drug excipient interaction (Jackson, Young et al. 2000). The interactions of drug with excipients sewer leads to changes in the chemical, physical and therapeutic properties can be termed as incompatibilities (Chadha and Bhandari 2014) and it whitethorn cause the drug degradation (Narang, Desai et al. 2012) and loss of pharmacological activity (Patil and Patil 2013). Lactose is most widely used as the excipient in the solid dosage forms. Lactose is available in different form and different cross with diffe rent physical characteristics. Lactose is very popular excipient because of low comprise and inertness but in other hand lactose have interaction drug with aminic functional group i.e. lactose undergoes maillard Monajjemzadeh, 2009The maillard reaction is named Louis Maillard who report over 80 years ago that some amine and reduction sugars interact each other and forms brown pigments. The first yield of this reaction is simple glycosamine (Wirth, Baertschi et al. 1998).In this study, we attempted to explore the modes of interaction and energy concealment of the different isomers of isoniazid pull, pyrazinamide draw and confusablely study the biological activity of isoniazid adduct and pyrazinamide adduct compare with the help of various molecular(a) modelling techniques.In treatment of tuberculosis, isoniazid and pyrazinamide are key components of first line regimen (Hemanth, Sudha et al. 2012). isoniazid is chemically isonicotohydrazide and pyrazinamide is chemically pyr azine-2-carboxamide. isoniazid and pyrazinamide is hypersensitised for hydrolysis and oxidation interact with excipient particularly carbohydrate and trim sugars to form hydrazones. The hydrazone is mainly form by the interaction of isoniazid with lactose. There are as well as reported incompatibilities between lactose and other drugs containing primary and secondary amino functional group (Haywood, Mangan et al. 2005). In this study we were investigated the interaction between lactose with isoniazid and pyrazinamide for that different analytical technique were used and also make the in-sillico evaluation of isoniazid and pyrazinamide.Materials and methodsMaterialsIsoniazid and Pyrazinamide was generously supplied as a vest take by Macleods pharmaceutics Ltd., Wapi (Gujarat), India. Lactose monohydrate was purchased from Merck, Merck specialtiesPvt.Ltd. Mumbai, India. All other chemicals were of high-performance liquid state chromatography (HPLC) and analytical grade.MethodsA nalytical methodsUV-visible spectrophotometryThe Ultraviolet-visible spectra of Isoniazid, Pyrazinamide and the Isoniazidlactose adduct, Pyrazinamide-lactose adductwere record on a double beam UV-visible spectrophotometer (UV-1700 Shimadzu, Japan).An accurately weighed quantity of about 10 mg of isoniazid, 10 mg of pyrazinamide, 11.66 mg isoniazid-lactose adduct (equivalent to 10 mg isoniazid), 13.33 mg of pyrazinamide-lactose adduct (equivalent to 10 mg pyrazinamide) each turn separately in one C ml of distilled irrigate. From this, one ml of solution was diluted to 10.0 mL with of distilled wet to obtain concentration of 10 ppm. All solutionswere scanned in UV-Visible rove at 420 and 490 nm (Yates, Jones et al. 2003).Fourier-Transform infrared spectroscopyThe Fourier-transform infrared spectroscopy (FTIR) spectra of isoniazid, pyrazinamide, lactose, a isoniazidlactose physical mixture, pyrazinamide-lactose physical mixture and the isoniazidlactose adduct, pyrazinamide-lactose were recorded. The spectra were obtained utilize the diffuse reflectance scan method using KBr on an FT-IR spectrophotometer (IR Affinity 1 Shimadzu, Japan). The scanning execute was 4004000 cm-1. Each sample was scanned 45 times consecutively to obtain FT-IR spectrum.HPLC psycho compendiumThe HPLC (Gradient) system used for analysis consisted of Agilent Technologies 1200 series equipment, a G1315D quaternary pump, a G1315D diode legions detector and a rheodyne injector fitted with a 20 L loop. Data were recorded and evaluated using the EZChrome Elite software package. samplings were analyzed using LunaC18 column (250 4.6 mm i.d. 5 m) (Phenomenex) as stationary physique. The mobile phase was water wood alcohol (9505, v/v), flow rate of 0.8 mL/min with detection at 266 nm for isoniazid and 269 nm for pyrazinamide.Differential scanning calorimetryThermal analysis of Isoniazid, pyrazinamide, isoniazidlactose adduct and pyrazinamide-lactose was performed by differential scannin g calorimetry (DSC) using a TA 6000 Mettler toledo thermal analyzer. Individual samples as wellspring as the Maillard adduct (about 2 mg) were weighed in the DSC aluminum pan and were scanned in the temperature range of 25300C. A heating rate of 10C/min was used. The thermograms were reviewed for evidence of interaction. galvanic pile SpectrometryThe Mass spectrometry was performed using 410 Prostar binary LC with 500 MS with Electro spray Positive ionization and invalidating Ionization mode and Mass range is 50-2000 amu. The Isoniazid-lactose, Pyrazinamide-lactose adduct solution dismissd in mobile phase to obtain concentration about 100g/mL. In the positive ion mode with electrospray ionization technique, the sample was analyzed. closing of lactose in pharmaceutical tablet dosage formsThe presence of lactose in DOTs tablets was initially examined according to Indian Pharmacopoeia 2007 by taking 5ml modify solution of tablet powder and then add 5ml 1 M NaOH, Heat and cool at ro om temperature finally add super C cupri tatatarate the solution becomes red color shows presence of lactose.Preparation of adductSample Prepared in alkaline borate bufferAccurately weighed quantity of Isoniazid 300 mg (equivalent to dose of isoniazid) and 50 mg lactose monohydrate dissolve in alkaline borate buffer pH 9.2 by stirring and ultrasonography in 100 ml lucubrate bottom flask. In similar way 750 mg pyrazinamide (equivalent to dose of pyrazinamide) was dissolve with 250 mg lactose monohydrate in alkaline borate buffer pH 9.2 in 100 ml round bottom flask. The cleared solutions were refluxed at 600C for 12 hour on water bath. The reaction mixture filtered was diluted with menthol water (11). The adduct was subjected to HPLC analysis (gradient and isocratic run) and Mass spectrometry (LC-MS) analysis. The intensity of brown color was determined was spectrophotometrically after looseness weighed quantity in distilled water.Docking studyThe molecular docking tool, gliding (Schrodinger Inc., USA) (2006) was used for ligand docking study. The protein preparation was carried out using protein preparation mavin in Maestro 9.0.ResultUV-Visible spectroscopyThe UV-visible immersion spectrum of the isoniazidlactose adduct and pyrazinamidelactose adduct had shown an increase in absorption in the visible range as compared with isoniazid and pyrazinamide in distilled water as the solvent. The increased absorption the visible region (brown color) is due to Melanoidins harvestingion as the end products of the Maillard reaction as reported earlier (Shen, Tseng et al. 2007).FT-IR spectroscopyThe FT-IR absorption patterns of Isoniazid, Pyrazinamide, lactose, Isoniazidlactose physical mixture immediately after premix and pyrazinamide-lactose physical mixture immediately after mixing as well as Isoniazidlactose adduct, Pyrazinamide-lactose adduct were recorded.The card at 1678 cm1 in the IR spectrum of Isoniazid-lactose adduct, 1614 cm1 Pyrazinamide-lactose adduc t can be attributed to the imines make-up. The peak of NH bending is present at 1552 cm1 and 1583 cm-1 in the IR spectrum of Isonizid and Pyrazinamide and its physical mixture respectively. The peak present in spectrum of Isonizid and Pyrazinamide and its physical mixture are absent in Isoniazid-lactose adduct and Pyrazinamide-lactose adduct both these observations support the formation of adduct. The NH stretching band of secondary amine appears at 3302 cm1 and at 3292 cm-1 for Isonizid and Pyrazinamide respectively. The peak for the lactose OH appears at 3522 cm1 in the infrared spectra of lactose. The peaks for NH and OH stretching appear in the spectrum of the physical mixture, but the peak for NH disappears in the spectrum of the adduct. This may indicate the reaction of the amine with the reducing sugar, or it may be due overlapping of NH stretching peak with that of OH. The FTIR spectra of Isoniazid, Pyrazinamide, Lactose physical mixture, Isoniazid-lactose adduct and Pyrazi namide-lactose adduct shows an interaction between Isoniazid and Pyrazinamide with lactose leading to the formation of a Maillard product (Pavia et al 2009).Differential scanning calorimetryThe DSC thermograms show the presence of dissolve points for isoniazid and pyrazinamide at 171.61C and 189.55 C. The DSC thermogram of lactose shows the peak at 209.83 C. The adduct shows the disappearance of the melting point peak of isoniazid, pyrazinamide, paracetamol and vildagliptine in adduct samples confirms the formation of adduct.Gradient HPLC analysisInitially a gradient run of water and methyl alcohol was performed to obtain preliminary information regarding the unknown peaks in maillard reaction products (Shen, Tseng et al. 2007).The mobile phase was optimized to separate the Isoniazid-lactose adduct and Pyrazinamide-lactose adduct was water methanol (9505, v/v) with a flow rate 0.8ml/min at ambient temperature. The Isoniazid-lactose adduct and Pyrazinamide-lactose adduct elutes at 3.833min and 1.613 min respectively. The halt samples for isoniazid and pyrazinamide (without lactose) were also analyzed which proves method selectivity.Isocratic HPLC analysisThe optimized isocratic HPLC analysis of the Isoniazid-lactose adduct and Pyrazinamide-lactose revealed one especial(a) peak that eluted before Isoniazid and Pyrazinamide elution respectively. Performing analysis under identical chromatographic parameters, no another peak was observed in control samples.Mass spectrometryThe Isoniazid-lactose and Pyrazinamide-lactose adduct dissolve in mobile phase to obtain drug concentration about 100g/ml.In the positive ion mode with electrospray ionization technique, the sample was analyzed. The MS spectra show the forerunner ion for Isoniazid-lactose adduct and Pyrazinamide-lactose adduct was protonated molecule (M+H+) m/z 463.3 and 448.1 respectively. The Isoniazid-lactose adduct and Pyrazinamide-lactose adduct molecular mass was consistent with Isoniazid-lactose add uct and Pyrazinamide-lactose adduct condensation product respectively. The loss of one water molecule from parent leads to maillard-type condensation product.Docking studyIsoniazidIn docking study, isoniazid shows adhere with ARG-38 amino acid in the selected structure of protein (PDB calculate 3I6N) and isoniazid-lactose adduct shows binding with ASN-72, SER-69, SER-173, ALA-134 and PRO-132 amino acid in the selected structure of protein (PDB engrave 3I6N) as shown in table No. 1.1.PyrazinamidePyrazinamide shows binding with ALA-131 amino acid in the selected structure of protein (PDB code 3PL1) and pyrazinamide-lactose adduct shows binding with ASP-133 and LEU-131 amino acid in the selected structure of protein (PDB code 3PL1).DiscussionOn the above observation difficulties in the formulating a saucily pharmaceutical dosage form have often experienced because of the interaction between the lactose and active ingredients itself i.e. isoniazid and pyrazinamide. Although the nat ure and intensity of this interaction may alter the stability, dissolution rate and consequently absorption of the drug and also affect the pharmacological effect. it indicates that such interactions involving in the formation of the complexes and it canvass by different analytical techniques.The UV results shows increased absorption in the visible region (brown color) is due to Melanoidins production as the end products of the Maillard reaction as reported earlier in Shen, Tseng et al. 2007. The FTIR spectra of Isoniazid, Pyrazinamide, Lactose physical mixture, Isoniazid-lactose adduct and Pyrazinamide-lactose adduct shows peak of C=N it shows that formation of a Maillard product. HPLC analysis of the Isoniazid-lactose adduct and Pyrazinamide-lactose revealed one extra peak of impurity or maillard reaction product that eluted before Isoniazid and Pyrazinamide elution respectively. The MS spectra show the precursor ion for Isoniazid-lactose adduct and Pyrazinamide-lactose adduct an d it has same molecular weight related to maillard-type condensation product.In the docking study of isoniazid adduct and pyrazinamide adduct shows more binding than isoniazid and pyrazinamide but this is pseudo results because this binding present at hydroxyl radical group and hydroxyl group are responsible for the increase riddance of the isoniazid and pyrazinamide and it may be reduces the therapeutic effect of isoniazid and pyrazinamide. In spite of that analytical study confirm the occurrence of maillard reaction product in lactose containing solid dosage forms of amino functional group containing drugs but lactose is still preferred as excipient in the isoniazid and pyrazinamide containing anti-tubercular formulation i.e. DOTs.ConclusionThe present study reports that antitubercular drugs i.e. isoniazid and pyrazinamide undergoes maillard reaction and that confirmed by UV, FT-IR, HPLC and MS. The docking study of isoniazid adduct and pyrazinamide adduct more binding than isoni azid and pyrazinamide but it is pseudo results pharmacologically the excretory product of isoniazid and pyrazinamide increase and it ultimately reduces the therapeutic activity. A drugs- excipient interaction study can be actively used to the advantage of the formulator to increase the bioavailability of the drug. By compiling the data the use of lactose in the formulation of isoniazid and pyrazinamide, secondary amines needs to reconsideration.ReferencesChadha, R. and S. Bhandari (2014). Drugexcipient compatibility screeningRole of thermoanalytical and spectroscopic techniques. diary of pharmaceutical and biomedical analysis87 82-97.Crowley, P. J. (1999). Excipients as stabilizers. Pharmaceutical wisdom technology today2(6) 237-243.Haywood, A., et al. (2005). unwritten isoniazid mixture stability implications. Journal of Pharmacy Practice and Research35(3) 181.Hemanth, A. K., et al. (2012). uncomplicated and rapid liquid chromatography method for simultaneous determination of isoniazid and pyrazinamide in plasma. SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS9(1) 13-18.Indian Pharmacopoeia, (2007). Government of India, Ministry of health and family walefare, published by the Indian Pharmacopoeia Commission, Gaziabad vol. II III, pp. 658, 478, 628, 1009, 1008.Jackson, K., et al. (2000). Drugexcipient interactions and their affect on absorption. Pharmaceutical science technology today3(10) 336-345.MONAJJEMZADEH, F., HASSANZADEH, D., VALIZADEH, H., SIAHI-SHADBAD, M. R., MOJARRAD, J. S., ROBERTSON, T. A. ROBERTS, M. S. 2009b. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets. European Journal of Pharmaceutics and Biopharmaceutics, 73, 404-413.Narang, A. S., et al. (2012). Impact of excipient interactions on solid dosage form stability. Pharmaceutical research29(10) 2660-2683.PAVIA, D. L. 2009. Introduction to spectroscopy, CengageBrain. comPatil, D. D. and C. R. Patil (2013). Modification of pharmacologic al activity of nebivolol due to Maillard reaction. Pharmaceutical development and technology18(4) 844-851.Petrella, Stphanie Gelus-Ziental, Nathalie Maudry, Arnaud Laurans, Caroline Boudjelloul, RachidSougakoff, Wladimir(2011).Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis insights into natural and acquired granting immunity to pyrazinamide.PLoS One,6(1)e15785.Singh, Amit K Kumar, Ramasamy P Pandey, Nisha Singh, Nagendra Sinha, Mau Bhushan, AshaKaur, PunitSharma, SujataSingh, Tej P (2010). Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases BINDING STUDIES AND CRYSTAL STRUCTURE OF BOVINE LACTOPEROXIDASE WITH ISONIAZID AT 2.7 RESOLUTION.Journal of biological chemistry, 285(2) 1569-1576.Shen, S.-C., et al. (2007). An analysis of Maillard reaction products in ethanolic glucoseglycine solution. Food chemistry102(1) 281-287.Wirth, D. D., et al. (1998). Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. Journal of p harmaceutical sciences87(1) 31-39.Yates, E. A., et al. (2003). zap enhanced reaction of carbohydrates with amino-derivatised labels and glass surfaces. Journal of Materials Chemistry13(9) 2061-2063.